Guardant Health, Inc. GH

Abbott will sell Freenome’s SimpleScreen CRC test in the U.S. alongside the Cologuard Plus stool-based test it gained in the $21 billion acquisition of Exact Sciences.

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.

Brian Shaw and Constantine Malaxos join as enterprise customers expand across financial services, healthcare, and technologySAN FRANCISCO, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Coverbase, AI engineered for third-party risk management (TPRM), today announced that Brian Shaw has joined as GTM Lead and Constantine Malaxos as Head of Alliances. Both bring decades of experience building and selling third-party risk technology to large enterprises. In less than a year since closing its Series A, Coverbas